Fibromyalgia Clinical Trial
Official title:
Effects of Pain Therapeutic Education and Hydrotherapy on Pain, Depression, Anxiety, Quality of Life and Quality of Sleep of Women With Fibromyalgia
Verified date | November 2020 |
Source | Universidade Federal de Sao Carlos |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Fibromyalgia (FM) is a prevalent and disabling disease, that affects mostly women and its main characteristic is chronic pain. Several studies have shown that hydrotherapy is effective in the improvement of symptoms and quality of life of this population; other studies have shown that Pain Therapeutic Education (PTE) is also effective in this sense. PTE is one cheap, easy to apply intervention, with very positive results in chronic pain situations. However, there is a lack of studies that have shown the effects of this intervention on FM. Hence, this study will aim to verify the effectiveness of the hydrotherapy and PTE on women with FM. Sixty women will be randomly allocated in two groups: hydrotherapy and hydrotherapy + PTE. Before treatment start, the investigators will evaluate pain (visual analogue scale, presence of myofascial trigger points and pressure pain threshold over the scalene, upper trapezius, infraspinatus, piriformis, iliopsoas and soleus, bilaterally), quality of life (Fibromyalgia Impact Questionnaire and medical outcomes study 36-item short-form health survey), depression (Beck Depression Inventory), anxiety (Beck Anxiety Inventory) and sleep quality (Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale). Hydrotherapy treatment will last 12 weeks. Women will be evaluated other 3 times: after 6 and 12 weeks (treatment middle and end) and 12 weeks after treatment completion (follow-up). Women in the hydrotherapy group will receive a folder with explanations on FM. Women in the hydrotherapy + PTE will participate of 4 meetings over 12 treatment weeks, in which themes like pain physiology, pain chronification and exacerbation and pain self-management, as well as information on FM will be approached. Statistical analysis will include qualitative and quantitative variable description. Correlation among variables will also be analyzed. Level of significance will be set at 5%.
Status | Completed |
Enrollment | 90 |
Est. completion date | November 3, 2020 |
Est. primary completion date | October 31, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Clinical and medical Fibromyalgia Diagnosis according to ACR Diagnostic criteria 2010 and 2016; - Willing to perform hydrotherapy as treatment. Exclusion Criteria: - Cognitive deficits that prevent volunteers from understanding evaluation and treatment procedures; - Uncontrolled systemic illnesses (diabetes, hypertension); - Neurological and musculoskeletal conditions that may interfere in the evaluation and treatment procedures (palsies, sensitivity alterations, advanced osteoarthritis); - Infecto-contagious illnesses (especially in the urinary tract); - Alcohol or drug abuse; - Pregnancy. |
Country | Name | City | State |
---|---|---|---|
Brazil | Federal University of São Carlos | Sao Carlos | SP |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal de Sao Carlos |
Brazil,
Ortega E, Bote ME, Giraldo E, García JJ. Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports. 2012 Feb;22(1):104-12. doi: 10.1111/j.1600-0838.2010.01132.x. Epub 2010 Jun 1. — View Citation
Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013 Aug;17(8):356. doi: 10.1007/s11916-013-0356-5. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Pain throughout time | Visual Analogue Scale (VAS - 100mm) for pain | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in number of active myofascial trigger points throughout time | Number of active myofascial trigger points | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in depression throughout time | Depression clinical symptoms (measured through Hospital Anxiety and Depression Scale) | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in anxiety throughout time | Anxiety clinical symptoms (measured through Hospital Anxiety and Depression Scale) | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in Impact of Fibromyalgia in Quality of life throughout time | Quality of life measured through Revised Fibromyalgia Impact Questionnaire | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in Quality of life throughout time | Quality of life measured through questionnaire Medical Outcomes Sudy 36-item Short-Form Health Survey (sf-36) | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in Sleep throughout time | Sleep quality measured through two questionnaires: Pittsburgh Quality of Sleep Index and Epworth Sleepiness Scale | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in Pain neurophysiology learning throughout time | For the Pain Therapeutic Education group, index of Pain Neurophysiology learning with an specific questionnaire | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in knowledge of Fibromyalgia throughout time | Fibromyalgia Knowledge will be measured through Fibromyalgia Knowledge Questionnaire | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Changes in Appraisal of Self-Care Agency throughout time | Appraissal of Self-Care Agency through The Appraisal of Self-Care Agency Scale - Revised (ASAS-R) scores | Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Pacient satisfaction with the intervention | Structured questionnaire through which patient will answer about satisfaction with treatment, with a 5-point Likert Scale, with the possible asnswers: "Totally Agree", "Agree", "Neutral", "Disagree" and "Totally Disagree", relative to the following affirmations: 1) I am satisfied with the treatment I received; 2) I believe this treatment was helpful for my condition; 3) I believe my health status has improved after treatment; 4) I will include in my daily life activities things I have learned during my treatment; 5) I will recommend this treatment to someone who has the same health condition as me. | After 6 and 12 weeks of treatment and after 12 weeks of treatment completion. | |
Secondary | Patient's perception of change | Self-perception of change with the Global Rating of Change Scale; with this scale from -7 to 7, the participant will rate her perception of change after intervention. The negative values will be considered as a worsening in the health status, and the positive values, as a improvement in the health condition of the participant. Zero will be considered as no change in the health status. | After 6 and 12 weeks of treatment and after 12 weeks of treatment completion. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A |